TNFRSF1A and type 2 diabetes mellitus: Previous studies reported that TNF-RI could be a new biomarker for early renal decline in patients with type 2 diabetes and that serum sTNF-RI was correlated with plasma creatinine values in patients with sepsis syndrome [16–19], but relatively few investigations have evaluated the function of TNF-RI in patients with LN.